Chan Broad Spec Oral Suspension

Pajjiż: Irlanda

Lingwa: Ingliż

Sors: HPRA (Health Products Regulatory Authority)

Ingredjent attiv:

Rafoxanide; Levamisole hydrochloride

Disponibbli minn:

Chanelle Pharmaceuticals Manufacturing Limited

Kodiċi ATC:

QP52AE01; QP52AG05

INN (Isem Internazzjonali):

Rafoxanide; Levamisole hydrochloride

Dożaġġ:

22.5/15 milligram(s)/millilitre

Għamla farmaċewtika:

Oral suspension

Tip ta 'preskrizzjoni:

POM: Prescription Only Medicine as defined in relevant national legislation

Grupp terapewtiku:

Cattle, Sheep

Żona terapewtika:

levamisole; rafoxanide

Indikazzjonijiet terapewtiċi:

Endoparasiticide

L-istatus ta 'awtorizzazzjoni:

Authorised

Data ta 'l-awtorizzazzjoni:

1989-10-01

Karatteristiċi tal-prodott

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Chan Broad Spec Oral Suspension
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Oral suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle, sheep.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Chan Broad Spec is effective in the treatment and control of
roundworm, lungworm and fluke infections in cattle and
sheep.
It is highly effective against mature and developing immature stages
of levamisole-susceptible major nematode
species:
_Haemonchus_ spp,_ Ostertagia_ spp (except inhibited_ Ostertagia_
larvae in cattle),_ Nematodirus_ spp,
_Trichostrongylus_ spp,_ Cooperia_ spp,_ Oesophagostomum_ spp,_
Chabertia_ spp and_ Bunostomum_ spp and lungworms causing
hoose (husk) in cattle and sheep.
Chan Broad Spec is highly effective against mature fluke in cattle and
sheep and 83%
effective against 4-week old immature fluke in sheep.
Chan Broad Spec is also effective against_ Oestrus ovis_ in sheep.
4.3 CONTRAINDICATIONS
Do not use in animals with known hypersensitivity to the active
ingredients.
Do not use in animals less than 6 months of age.
Each ml contains:
Active Substances
Rafoxanide
22.5
mg
Levamisole Hydrochloride 15
mg
Excipients
Patent Blue V (E131)
0.005 mg
Sodium metabisulphite
1.0
mg
I
R
I
S
H
M
E
D
I
C
I
N
E
S
B
O
A
R
D
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_3_
_/_
_0_
_1_
_/_
_2_
_0_
_1_
_4_
_C_
_R_
_N_
_ _
_7_
_0_
_1_
_6_
_8_
_2_
_4_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_